If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCohort Regulatory News (CHRT)

Share Price Information for Cohort (CHRT)

Share Price is delayed by 15 minutes
Get Live Data
1,380.00    -18.00 (-1.29%)
Bid:
1,374.00
Ask:
1,388.00
Spread: 14.00 (1.019%)
Market Cap: £632.46m
CHRT Live PriceLast checked at - London Stock Exchange

Intraday Cohort Share Chart

Share Options

14 Aug 2013 10:38

RNS Number : 6754L
Cohort PLC
14 August 2013
 



14 August 2013 AIM: CHRT

PRESS RELEASE

COHORT PLC ("Cohort")

Share Options

Option Grant

Cohort announces that on 13 August 2013 the following approved options over ordinary shares of 10 pence each were granted to Cohort directors pursuant to the Cohort plc Savings Related Share Option Scheme established on 16 February 2006 (and approved by HM Revenue & Customs on 10 April 2006) ("SAYE Scheme"):

Director

Number of shares under this option

Exercise Price (pence)

Total number of shares under the SAYE Scheme following grant

AS Thomis

2,330

154.5

6,041

SR Walther

5,825

154.5

15,103

 

The options are made pursuant to three year savings contracts.

Option Exercise

Cohort announces that it has issued and allotted 170,164 new ordinary shares of 10p each in the capital of Cohort pursuant to the exercise of share options under the Cohort plc 2006 Share Option Scheme and the SAYE Scheme.

Following this exercise, Cohort's issued share capital consists of 40,958,616 ordinary shares of 10p each with voting rights. Cohort does not hold any shares in treasury.

Therefore, the total number of voting rights in Cohort is 40,958,616. This figure may be used by shareholders as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change to their interest in, Cohort under the FCA's Disclosure and Transparency Rules.

Application has been made for admission of these shares to trading on AIM and dealings in the new ordinary shares are expected to commence on 19 August 2013.

 

Ends

 

For further information, please contact

 

Cohort plc

 

Andrew Thomis, Chief Executive

Simon Walther, Finance Director

+44 (0)118 909 0390

 

Investec

Keith Anderson, Daniel Adams

+44 (0)20 7597 5970

MHP Communications

Reg Hoare, Vicky Watkins, Ben Griffiths

+44 (0)20 3128 8100

 

 

Cohort plc (www.cohortplc.com) (@Cohortplc)

 

Cohort is an independent technology group working primarily for defence (air, land and sea), wider government and industry clients, through three market-facing subsidiary companies:

Ÿ MASS (www.mass.co.uk) - a specialist systems house with considerable experience in the defence market and a focus on information systems. Based in Cambridgeshire, MASS was acquired by Cohort in August 2006;

 

Ÿ SCS (www.scs-ltd.co.uk) - a defence technical advisory business, combining technical expertise with practical experience and domain knowledge. Owned by Cohort since flotation in March 2006;

 

Ÿ SEA (www.sea.co.uk) - an advanced surveillance systems and software house with hardware development capability operating in the defence, space and transport market sectors. Acquired by Cohort in October 2007.

 

Cohort (AIM: CHRT) was admitted to London's Alternative Investment Market in March 2006. It has its headquarters in Berkshire and employs in total around 500 core staff there and at its other operating company sites in Bristol, Cambridgeshire, Lincolnshire and Somerset.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCSFWSULFDSEDA
Date   Source Headline
24th Sep 20247:00 amRNSAGM Statement
20th Sep 202410:48 amRNSDirector/PDMR Shareholding
16th Sep 20245:34 pmRNSHolding(s) in Company
2nd Sep 20245:08 pmRNSTotal Voting Rights
2nd Sep 202411:32 amRNSHolding(s) in Company
27th Aug 20245:54 pmRNSBlock listing six monthly return
21st Aug 20247:00 amRNSAnnual Report and Notice of Annual General Meeting
19th Aug 20243:48 pmRNSDirector/PDMR Shareholding
16th Aug 202412:10 pmRNSHolding(s) in Company
12th Aug 20244:22 pmRNSDirector/PDMR Shareholding
2nd Aug 20242:30 pmRNSDirector/PDMR Shareholding
1st Aug 202411:43 amRNSTotal Voting Rights
29th Jul 20249:45 amRNSDirector/PDMR Shareholding
23rd Jul 20245:04 pmRNSDirector/PDMR Shareholding
17th Jul 20247:01 amRNSContract win
17th Jul 20247:00 amRNSFinal Results
15th Jul 20247:00 amRNSContract Award
11th Jul 20247:00 amRNSNotice of Results
1st Jul 20249:33 amRNSTotal Voting Rights
5th Jun 202410:59 amRNSEBT Purchase of Shares
31st May 20243:17 pmRNSTotal Voting Rights
23rd May 20241:30 pmRNSEBT Purchase of Shares
23rd May 20247:00 amRNSFull Year Trading Update
20th May 20244:01 pmRNSEBT Purchase of Shares
14th May 20242:10 pmRNSEBT Purchase of Shares
7th May 20245:24 pmRNSEBT Purchase of Shares
3rd May 202411:44 amRNSDirector/PDMR Shareholding
1st May 20245:17 pmRNSDirector/PDMR Shareholding
1st May 20245:11 pmRNSTotal Voting Rights
30th Apr 20247:00 amRNSBlock Listing Application
30th Apr 20247:00 amRNSSite visit to SEA
15th Apr 20247:00 amRNSDirector/PDMR Shareholding
8th Apr 20242:19 pmRNSDirector/PDMR Shareholding
2nd Apr 20243:19 pmRNSBlock Listing Six Monthly Return
2nd Apr 20243:17 pmRNSTotal Voting Rights
28th Mar 20242:06 pmRNSHolding(s) in Company
27th Mar 20244:00 pmRNSDirector/PDMR Shareholding
26th Mar 20247:00 amRNSContract Win
19th Mar 20249:43 amRNSContract win
13th Mar 202410:49 amRNSDirector/PDMR Shareholding
1st Mar 20247:00 amRNSTotal Voting Rights
26th Feb 20244:28 pmRNSBlock listing six monthly return
16th Feb 202412:38 pmRNSDirector/PDMR Shareholding
1st Feb 202410:02 amRNSTotal Voting Rights
29th Jan 20247:00 amRNSContract Win
17th Jan 20243:25 pmRNSDirector/PDMR Shareholding
15th Jan 20247:00 amRNSInterim Report 2023
2nd Jan 202412:05 pmRNSTotal Voting Rights
22nd Dec 202312:07 pmRNSHolding(s) in Company
13th Dec 20237:01 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.